JP2007512285A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512285A5
JP2007512285A5 JP2006540389A JP2006540389A JP2007512285A5 JP 2007512285 A5 JP2007512285 A5 JP 2007512285A5 JP 2006540389 A JP2006540389 A JP 2006540389A JP 2006540389 A JP2006540389 A JP 2006540389A JP 2007512285 A5 JP2007512285 A5 JP 2007512285A5
Authority
JP
Japan
Prior art keywords
chemical substance
chlorobenzyloxy
benzenesulfonyl
tetrahydro
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006540389A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512285A (ja
Filing date
Publication date
Priority claimed from GBGB0327740.7A external-priority patent/GB0327740D0/en
Application filed filed Critical
Publication of JP2007512285A publication Critical patent/JP2007512285A/ja
Publication of JP2007512285A5 publication Critical patent/JP2007512285A5/ja
Pending legal-status Critical Current

Links

JP2006540389A 2003-11-28 2004-11-25 抗精神病薬としての7−[4−(4−クロロベンジルオキシ)ベンゼンスルホニル]−8−メトキシ−3−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピニウムマレエートもしくはトシレート Pending JP2007512285A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds
PCT/EP2004/013416 WO2005051916A1 (en) 2003-11-28 2004-11-25 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics

Publications (2)

Publication Number Publication Date
JP2007512285A JP2007512285A (ja) 2007-05-17
JP2007512285A5 true JP2007512285A5 (https=) 2008-01-17

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006540389A Pending JP2007512285A (ja) 2003-11-28 2004-11-25 抗精神病薬としての7−[4−(4−クロロベンジルオキシ)ベンゼンスルホニル]−8−メトキシ−3−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピニウムマレエートもしくはトシレート

Country Status (18)

Country Link
US (1) US20070275948A1 (https=)
EP (1) EP1687279A1 (https=)
JP (1) JP2007512285A (https=)
KR (1) KR20060103322A (https=)
CN (1) CN1906170A (https=)
AR (1) AR046719A1 (https=)
AU (1) AU2004293179A1 (https=)
BR (1) BRPI0417029A (https=)
CA (1) CA2547444A1 (https=)
GB (1) GB0327740D0 (https=)
IL (1) IL175663A0 (https=)
IS (1) IS8500A (https=)
MA (1) MA28177A1 (https=)
NO (1) NO20062970L (https=)
RU (1) RU2006122959A (https=)
TW (1) TW200528433A (https=)
WO (1) WO2005051916A1 (https=)
ZA (1) ZA200603781B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
KR101653548B1 (ko) * 2008-01-08 2016-09-02 머크 샤프 앤드 돔 리미티드 2-{4-[(3s)-피페리딘-3-일]페닐}-2h-인다졸-7-카복스아미드의 약제학적으로 허용되는 염
US20180228811A1 (en) * 2014-12-12 2018-08-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
JP2022504228A (ja) 2018-10-03 2022-01-13 テサロ, インコーポレイテッド ニラパリブ遊離塩基の結晶形態
WO2022093904A1 (en) * 2020-10-27 2022-05-05 Trevena, Inc. Crystalline and amorphous forms of a delta-opioid modulator
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518414A (ja) * 2001-12-21 2005-06-23 スミスクライン ビーチャム パブリック リミテッド カンパニー ドーパミン受容体のモジュレーターとしての7−スルホニル−3−ベンゾアゼピン誘導体およびcns障害の治療のためのその使用
MXPA04007920A (es) * 2002-02-13 2004-11-26 Glaxo Group Ltd Derivados de bencensulfonamida como agentes antisicoticos.
AR040126A1 (es) * 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento

Similar Documents

Publication Publication Date Title
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
WO2002015662A3 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
WO2006069242A3 (en) Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related?disorders
CA2462453A1 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
CA2417106A1 (en) Piperazine derivatives
WO2004043337A3 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
CA2432085A1 (en) Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
CA2388142A1 (en) Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
JP2007512285A5 (https=)
EP2042490A3 (en) Benzimidazole derivatives as vanilloid receptor antagonists
WO2003053945A3 (en) Urea derivatives and their use as vanilloid receptor antagonists
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
ATE386725T1 (de) Heterocyclylverbindungen
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
WO2006070325A3 (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
CY1105479T1 (el) Παραγωγα τετραζολιου και μεθοδοι αντιμετωπισης σχετιζομενων με τον μεταβολισμο διαταραχων με αυτα
WO2005118579A3 (en) Thiazole derivatives as chemokine receptor antagonists
WO2007067875A3 (en) Pyridinyl sulfonamide modulators of chemokine receptors
NO20050888D0 (no) Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DE60322419D1 (de) Pyrrolidin-2-on-derivate als inhibitoren von thrombin und faktor xa
NO20062970L (no) 7-[4-(4-klorobenzyloksy)benzensulfonyl]-8-metoksy-3-metyl-2,3,4,5-tetrahydro-1 H-3-benzazepiniummaleat eller tosyslat som antipsykotia
WO2002083627A3 (de) Liganden des integrins alpha-v-beta-6
JP2005534668A5 (https=)
Zhang et al. Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors